Home > Financial Ratios > CONCORD BIOTECH

CONCORD BIOTECH
Price to Cash Earnings (PCE)

    Back to All Ratios
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 41.1744.02---

What is the latest Price to Cash Earnings (PCE) ratio of CONCORD BIOTECH ?

The latest Price to Cash Earnings (PCE) ratio of CONCORD BIOTECH is 41.17 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202541.17
Mar202444.02
Mar2023-
Mar2022-
Mar2021-

How is Price to Cash Earnings (PCE) of CONCORD BIOTECH Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 41.17
-6.47
Mar2024 44.02
0
Mar2023 0
0
Mar2022 0
0
Mar2021 0 -

Other Financial Ratios of CONCORD BIOTECH


Compare Price to Cash Earnings (PCE) ratio of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹14,095.9 Cr 2% -2.3% -40.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,497.0 Cr -3.5% -6.4% -2.6% Stock Analytics
DIVIS LABORATORIES ₹165,492.0 Cr -5.8% -1.6% 10.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,013.0 Cr 1.4% 7% 23.7% Stock Analytics
CIPLA ₹112,922.0 Cr -4.7% -6.8% -0.3% Stock Analytics
DR REDDYS LABORATORIES ₹98,115.0 Cr -2.8% -8.1% -11.1% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

2%

-2.3%

-40.3%

SENSEX

-0.7%

-1.9%

8%


You may also like the below Video Courses